Thomas Radimerski

5.8k total citations · 1 hit paper
41 papers, 3.2k citations indexed

About

Thomas Radimerski is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Thomas Radimerski has authored 41 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Genetics and 17 papers in Oncology. Recurrent topics in Thomas Radimerski's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Cytokine Signaling Pathways and Interactions (12 papers) and Kruppel-like factors research (9 papers). Thomas Radimerski is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Cytokine Signaling Pathways and Interactions (12 papers) and Kruppel-like factors research (9 papers). Thomas Radimerski collaborates with scholars based in Switzerland, United States and United Kingdom. Thomas Radimerski's co-authors include Jacques Montagne, Ernst Hafen, George Thomas, Hugo Stocker, Sophie Raisin, Julien Colombani, Sophie Pantalacci, Pierre Léopold, Felix Rintelen and Sean Oldham and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Thomas Radimerski

41 papers receiving 3.2k citations

Hit Papers

A Nutrient Sensor Mechanism Controls Drosophila Growth 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Nutrient Sensor Mechanism Controls Drosophila Growth
    2003 599 citations Julien Colombani, Sophie Raisin et al. Cell profile →

Peers

Thomas Radimerski
Felix Rintelen Switzerland
Benoît Biteau United States
Ville Hietakangas Finland
Patrick J Hu United States
Marc Therrien Canada
Pascale F. Dijkers Netherlands
Nico P. Dantuma Sweden
Nicholas S. Tolwinski Singapore
Felix Karim United States
Rita Derua Belgium
Felix Rintelen Switzerland
Thomas Radimerski
Citations per year, relative to Thomas Radimerski Thomas Radimerski (= 1×) peers Felix Rintelen

Countries citing papers authored by Thomas Radimerski

Since Specialization
Citations

This map shows the geographic impact of Thomas Radimerski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Radimerski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Radimerski more than expected).

Fields of papers citing papers by Thomas Radimerski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Radimerski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Radimerski. The network helps show where Thomas Radimerski may publish in the future.

Co-authorship network of co-authors of Thomas Radimerski

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Radimerski. A scholar is included among the top collaborators of Thomas Radimerski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Radimerski. Thomas Radimerski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lichitsky, Boris V., Andrey N. Komogortsev, Mikhail M. Krayushkin, et al.. (2019). Benzimidazolyl-pyrazolo[3,4-b]pyridinones, Selective Inhibitors of MOLT-4 Leukemia Cell Growth and Sea Urchin Embryo Spiculogenesis: Target Quest. ACS Combinatorial Science. 21(12). 805–816. 11 indexed citations
2.
Schlapbach, Achim, Láśzló Révész, Carole Pissot‐Soldermann, et al.. (2018). N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity. Bioorganic & Medicinal Chemistry Letters. 28(12). 2153–2158. 18 indexed citations
3.
Akahane, Koshi, Takaomi Sanda, Marc R. Mansour, et al.. (2015). HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia. Leukemia. 30(1). 219–228. 33 indexed citations
4.
Frismantas, Viktoras, Maria Pamela Dobay, Anna Maria Rinaldi, et al.. (2015). Drug Response Profiling to Identify Selective Pharmacological Activity in Drug Resistant ALL. Blood. 126(23). 2532–2532. 1 indexed citations
5.
Ringel, Frauke, Jaspal Kaeda, Michaela Schwarz, et al.. (2014). Effects of Jak2 Type 1 Inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 Mutation-Positive and Bcr-Abl-Positive Cell Lines. Acta Haematologica. 132(1). 75–86. 6 indexed citations
6.
Ebel, Nicolas, Vincent Romanet, Rita Andraos, et al.. (2013). JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease. Clinical Cancer Research. 19(22). 6230–6241. 59 indexed citations
7.
Britschgi, Adrian, Thomas Radimerski, & Mohamed Bentires‐Alj. (2013). Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts?. Drug Resistance Updates. 16(3-5). 68–72. 21 indexed citations
8.
Britschgi, Adrian, Rita Andraos, Heike Brinkhaus, et al.. (2012). JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer. Cancer Cell. 22(6). 796–811. 193 indexed citations
9.
Massey, Andrew J., Joseph Schoepfer, Paul A. Brough, et al.. (2010). Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800. Molecular Cancer Therapeutics. 9(4). 906–919. 50 indexed citations
10.
Gerspacher, Marc, Pascal Furet, Carole Pissot‐Soldermann, et al.. (2010). 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1724–1727. 21 indexed citations
11.
Montagne, Jacques, Jean-Philippe Parvy, Thomas Radimerski, et al.. (2010). The Nuclear Receptor DHR3 Modulates dS6 Kinase–Dependent Growth in Drosophila. PLoS Genetics. 6(5). e1000937–e1000937. 15 indexed citations
12.
Pissot‐Soldermann, Carole, Marc Gerspacher, Pascal Furet, et al.. (2010). Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2609–2613. 33 indexed citations
13.
Furet, Pascal, Joseph Schoepfer, Thomas Radimerski, & Patrick Chêne. (2009). Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I. Bioorganic & Medicinal Chemistry Letters. 19(15). 4014–4017. 43 indexed citations
14.
Chêne, Patrick, Joseph Schoepfer, Pascal Furet, et al.. (2009). Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue. SHILAP Revista de lepidopterología. 9(1). 1–1. 71 indexed citations
15.
Stocker, Hugo, Thomas Radimerski, Benno Schindelholz, et al.. (2003). Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nature Cell Biology. 5(6). 559–566. 419 indexed citations
16.
Colombani, Julien, Sophie Raisin, Sophie Pantalacci, et al.. (2003). A Nutrient Sensor Mechanism Controls Drosophila Growth. Cell. 114(6). 739–749. 599 indexed citations breakdown →
17.
Jünger, Martin A., Felix Rintelen, Hugo Stocker, et al.. (2003). The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. Journal of Biology. 2(3). 20–20. 480 indexed citations
18.
Radimerski, Thomas, Jacques Montagne, Felix Rintelen, et al.. (2002). dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nature Cell Biology. 4(3). 251–255. 149 indexed citations
19.
Radimerski, Thomas, Jacques Montagne, Maja Hemmings-Mieszczak, & George Thomas. (2002). Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes & Development. 16(20). 2627–2632. 153 indexed citations
20.
Oldham, Sean, Jacques Montagne, Thomas Radimerski, George Thomas, & Ernst Hafen. (2000). Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes & Development. 14(21). 2689–2694. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix Rintelen Breakdown of academic impact, for papers by Benoît Biteau Breakdown of academic impact, for papers by Ville Hietakangas Breakdown of academic impact, for papers by Patrick J Hu Breakdown of academic impact, for papers by Marc Therrien Breakdown of academic impact, for papers by Pascale F. Dijkers Breakdown of academic impact, for papers by Nico P. Dantuma Breakdown of academic impact, for papers by Nicholas S. Tolwinski Breakdown of academic impact, for papers by Felix Karim Breakdown of academic impact, for papers by Rita Derua
Rankless by CCL
2026